Objectives

1. To evaluate study on effect of Canagliflozin on Renal and Cardiovascular outcomes across different levels of Albuminuria.

2. To determine clinical significance of study results.

Session date: 
Thursday, November 21, 2019 - 1:00pm to 2:00pm
Speaker Name: 
Dr. Samantha Gunning
Location: 
UCMC AMB S-644
5700 S Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.